Efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge model

por Torkildsen G, Narvekar A, Bergmann M
Publicado 2015

Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca

por Sheppard J, Bergmann M, Schechter BA, Luchs J, Ogundele A, Karpecki P
Publicado 2021

Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis

por McLaurin E, Bergmann M, Narvekar A, Adewale A, Gomes P, Torkildsen G
Publicado 2017

Hemorrhage in mouse tumors induced by dodecaborate cluster lipids intended for boron neutron capture therapy

por Schaffran T, Jiang N, Bergmann M, Küstermann E, Süss R, Schubert R, Wagner FM, Awad D, Gabel D
Publicado 2014